Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
2001 1
2003 1
2004 1
2005 3
2006 2
2009 2
2010 2
2011 2
2012 1
2014 2
2015 3
2016 3
2019 3
2020 1
2021 3
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Household transmission of SARS-CoV-2 infection in the Paris/Ile-de-France area.
Katlama C, Dudoit Y, Huyard J, Blanc C, Soulié C, Schneider L, Faycal A, Lenclume L, Hamani N, Qatib N, Tubiana R, Seang S, Sellem B, Costagliola D, Palich R, Valantin MA, Assoumou L. Katlama C, et al. Among authors: dudoit y. Eur J Clin Microbiol Infect Dis. 2022 Mar;41(3):445-454. doi: 10.1007/s10096-021-04345-9. Epub 2022 Jan 8. Eur J Clin Microbiol Infect Dis. 2022. PMID: 34997388 Free PMC article.
Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study.
Pourcher V, Capeau J, Dudoit Y, Boccara F, Soulié C, Ndoadoumgue AL, Charlotte F, Fellahi S, Bastard JP, Béréziat V, Lagathu C, Marcelin AG, Peytavin G, Boutron-Ruault MC, Tubbax C, D'Avout D'Auerstaedt A, Valantin MA, Schneider L, Costagliola D, Katlama C, Assoumou L, Pourcher G. Pourcher V, et al. Among authors: dudoit y. J Acquir Immune Defic Syndr. 2022 Jun 1;90(2):240-248. doi: 10.1097/QAI.0000000000002939. J Acquir Immune Defic Syndr. 2022. PMID: 35185138
High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
Abdi B, Ndoadoumgue AL, Djebara S, Zafilaza K, Palich R, Marot S, Schneider L, Wirden M, Seang S, Dudoit Y, Teyssou E, Tubiana R, Soulie C, Valantin MA, Katlama C, Calvez V, Assoumou L, Marcelin AG, Pourcher V. Abdi B, et al. Among authors: dudoit y. J Infect. 2022 Aug;85(2):e33-e36. doi: 10.1016/j.jinf.2022.05.036. Epub 2022 Jun 2. J Infect. 2022. PMID: 35662666 Free PMC article. No abstract available.
Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.
Faycal A, Ndoadoumgue AL, Sellem B, Blanc C, Dudoit Y, Schneider L, Tubiana R, Valantin MA, Seang S, Palich R, Bleibtreu A, Monsel G, Godefroy N, Itani O, Paccoud O, Pourcher V, Caumes E, Ktorza N, Chermak A, Abdi B, Assoumou L, Katlama C; COVIDOM-19 PSL research group. Faycal A, et al. Among authors: dudoit y. Infect Dis Now. 2022 Mar;52(2):75-81. doi: 10.1016/j.idnow.2021.11.003. Epub 2021 Nov 17. Infect Dis Now. 2022. PMID: 34800742 Free PMC article.
Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study.
Cousyn L, Sellem B, Palich R, Bendetowicz D, Agher R, Delorme C, Tubiana R, Valantin MA, Seang S, Schneider L, Fayçal A, Dudoit Y, Abdi B, Ndoadoumgue A, Assoumou L, Katlama C; COVIDOM-19 PSL group. Cousyn L, et al. Among authors: dudoit y. Infect Dis Now. 2021 Aug;51(5):440-444. doi: 10.1016/j.idnow.2021.03.004. Epub 2021 Mar 22. Infect Dis Now. 2021. PMID: 33766735 Free PMC article.
Dynamics in HIV-DNA levels over time in HIV controllers.
Avettand-Fenoel V, Bayan T, Gardiennet E, Boufassa F, Lopez P, Lecuroux C, Noel N, Trémeaux P, Monceaux V, Autran B, Meyer L, Saez-Cirion A, Lambotte O, Rouzioux C; CODEX ANRS Cohort Study Group. Avettand-Fenoel V, et al. J Int AIDS Soc. 2019 Jan;22(1):e25221. doi: 10.1002/jia2.25221. J Int AIDS Soc. 2019. PMID: 30629340 Free PMC article.
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
Palich R, Allavena C, Peytavin G, Soulie C, Tubiana R, Weiss L, Montoya Ferrer A, Duvivier C, Bouchaud O, Bottero J, Durand A, Lê MP, Marcelin AG, Dudoit Y, Assoumou L, Katlama C; ETRAL QD study group. Palich R, et al. Among authors: dudoit y. J Antimicrob Chemother. 2021 Jan 19;76(2):477-481. doi: 10.1093/jac/dkaa423. J Antimicrob Chemother. 2021. PMID: 33099638 Clinical Trial.
37 results